Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.
暂无分享，去创建一个
D. Donà | T. Metsvaht | M. Sharland | A. Dotta | I. Lutsar | E. Roilides | P. Heath | G. Mitsiakos | Michelle N Clements | V. Papaevangelou | K. Sarafidis | É. Jacqz-Aigrain | A. Walker | M. Ilmoja | Eugenio Baraldi | Louise F. Hill | M. Turner | Louise Rawcliffe | C. Alonso-Diaz | A. Mahaveer | D. Dona' | A. Walker